Condition: Chronic Kidney Diseases · End Stage Renal Disease · Arteriovenous Fistula · Sponsor: VenoStent
This is a prospective, randomized, multi-center clinical trial for chronic kidney disease (CKD) patients referred for creation of a new arteriovenous fistula (AVF) in order to assess the safety and effectiveness of SelfWrap, a bioabsorbable perivascular wrap.
This description comes directly from the study's public registry record.
Mark Barakat, MD · (832) 429-5362 · mark.barakat@venostent.com
Always discuss trial participation with your own doctor first.
| AKDHC Bullhead City | Bullhead City, Arizona, United States | Recruiting |
| AKDHC Marana Surgery Center | Marana, Arizona, United States | Recruiting |
| Arizona Kidney Disease & Hypertension Centers (AKDHC) Phoenix Surgery Center | Phoenix, Arizona, United States | Recruiting |
| Banner University Medical Center | Tucson, Arizona, United States | Recruiting |
| Orange County Vascular Access Center | Garden Grove, California, United States | Recruiting |
| Tallahassee Research Institute | Tallahassee, Florida, United States | Recruiting |
| Lutheran Medical Group | Fort Wayne, Indiana, United States | Recruiting |
| Surgical Associates of Lexington | Lexington, Kentucky, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| University of Missouri | Columbia, Missouri, United States | Recruiting |
| Saint Louis University | St Louis, Missouri, United States | Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06001827